Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.

A. Hirsch; R. Nijveldt; P.A. van der Vleuten; B.J. Biemond; P.A.F.M. Doevendans; A.C. van Rossum; J.G. Tijssen; F. Zijlstra; J.J. Piek

Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.

Translated title of the contribution: Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.

A. Hirsch
, R. Nijveldt
, P.A. van der Vleuten
, B.J. Biemond
, P.A.F.M. Doevendans
, A.C. van Rossum
, J.G. Tijssen
, F. Zijlstra
, J.J. Piek

Department of Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
Original language	Undefined/Unknown
Pages (from-to)	434-441
Number of pages	8
Journal	American Heart Journal
Volume	152
Issue number	3
Publication status	Published - 2006

Keywords

Econometric and Statistical Methods: General
Geneeskunde(GENK)
Bescherming en bevordering van de menselijke gezondheid
Other medical specialities

Cite this

Hirsch, A., Nijveldt, R., van der Vleuten, P. A., Biemond, B. J., Doevendans, P. A. F. M., van Rossum, A. C., Tijssen, J. G., Zijlstra, F., & Piek, J. J. (2006). Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial. American Heart Journal, 152(3), 434-441.

@article{7fa38dc91d45448f9337bb1198cdc454,

title = "Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.",

keywords = "Econometric and Statistical Methods: General, Geneeskunde(GENK), Bescherming en bevordering van de menselijke gezondheid, Other medical specialities",

author = "A. Hirsch and R. Nijveldt and \{van der Vleuten\}, P.A. and B.J. Biemond and P.A.F.M. Doevendans and \{van Rossum\}, A.C. and J.G. Tijssen and F. Zijlstra and J.J. Piek",

note = "HEBE investigators",

year = "2006",

language = "Undefined/Unknown",

volume = "152",

pages = "434--441",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Elsevier",

number = "3",

}

Hirsch, A, Nijveldt, R, van der Vleuten, PA, Biemond, BJ, Doevendans, PAFM, van Rossum, AC, Tijssen, JG, Zijlstra, F & Piek, JJ 2006, 'Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.', American Heart Journal, vol. 152, no. 3, pp. 434-441.

Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial. / Hirsch, A.; Nijveldt, R.; van der Vleuten, P.A. et al.
In: American Heart Journal, Vol. 152, No. 3, 2006, p. 434-441.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.

AU - Hirsch, A.

AU - Nijveldt, R.

AU - van der Vleuten, P.A.

AU - Biemond, B.J.

AU - Doevendans, P.A.F.M.

AU - van Rossum, A.C.

AU - Tijssen, J.G.

AU - Zijlstra, F.

AU - Piek, J.J.

N1 - HEBE investigators

PY - 2006

Y1 - 2006

KW - Econometric and Statistical Methods: General

KW - Geneeskunde(GENK)

KW - Bescherming en bevordering van de menselijke gezondheid

KW - Other medical specialities

M3 - Article

SN - 0002-8703

VL - 152

SP - 434

EP - 441

JO - American Heart Journal

JF - American Heart Journal

IS - 3

ER -

Hirsch A, Nijveldt R, van der Vleuten PA, Biemond BJ, Doevendans PAFM, van Rossum AC et al. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial. American Heart Journal. 2006;152(3):434-441.